BDBM353439 4-[4-(5-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-N-(pyrimidin-5-ylmethyl)cyclohex-3-en-1-amine::US9796708, Example 671
SMILES: COc1ccc(F)cc1-c1ccnc2[nH]c(cc12)C1=CCC(CC1)NCc1cncnc1
InChI Key:
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyclin-Dependent Kinase 9 (CDK9) (Homo sapiens (Human)) | BDBM353439 (4-[4-(5-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc. US Patent | Assay Description CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in... | US Patent US9796708 (2017) BindingDB Entry DOI: 10.7270/Q2WD42P4 | |||||||||||
More data for this Ligand-Target Pair |